Overweight  >>  AZD8329  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD8329 / AstraZeneca
AZ8329, NCT01207089: To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Administration of AZD8329

Completed
1
45
Europe
AZD8329, Placebo
AstraZeneca
Overweight, Healthy, Male
12/10
12/10

Download Options